|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8509 USD | -4.39% |
|
+22.03% | -36.97% |
| 07-15 | Rani Therapeutics Reports Positive Initial Phase 1A Data for Rt-114 for the Treatment of Obesity | CI |
| 07-15 | Rani Therapeutics Reports Positive Initial Phase 1a Data for RT-114 in Obesity | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 0.8967 | 1.39 | 2.2 |
| Spread/Res. | -5.11% | -38.78% | -61.32% |
| Spread/Supp. | +15.63% | +34.51% | +85.70% |
| Support | 0.7359 | 0.6326 | 0.4582 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RANI Stock
- Charts Rani Therapeutics Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
